Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

p16 immunoreactivity in endometrial stromal cells: stromal p16 expression characterises but is not specific for endometrial polyps

Stewart, Colin J. R.1,2; Bharat, Chrianna3,4; Crook, Maxine1

Pathology - Journal of the RCPA: February 2015 - Volume 47 - Issue 2 - p 112–117
doi: 10.1097/PAT.0000000000000211
ANATOMICAL PATHOLOGY
Buy

Summary: It has been proposed recently that stromal cell p16 immunoreactivity may be useful in the diagnosis of endometrial polyps (EPs). However, the specificity of p16 staining is uncertain and it is also unclear whether sporadic and tamoxifen-related polyps show similar findings. We performed p16 immunostaining on 35 normal endometrial specimens and 32 EPs, six of which were associated with tamoxifen therapy. Normal cyclical endometrium showed patchy glandular staining and there was also focal stromal p16 expression in the functional layer of most proliferative and secretory endometria. Atrophic and lower uterine segment endometrial stromal cells were negative except for localised immunoreactivity in one atrophic case. The EPs demonstrated glandular p16 expression, particularly in epithelium showing ciliated metaplasia. Stromal p16 staining was also seen in all EPs, although the proportion of positive cells varied considerably (20–90%). There was no significant difference in staining between sporadic and tamoxifen-associated cases. In conclusion, stromal p16 immunoreactivity is characteristic of EPs and this may reflect the pathogenesis of polyp formation. Immunohistochemistry can help to distinguish polypoid and non-polypoid mucosa, particularly in small or disrupted biopsy specimens. However, stromal p16 expression is not completely specific since focal staining may be present in normal endometrium.

1Department of Histopathology, King Edward Memorial Hospital, Perth

2School for Women's and Infants’ Health, University of Western Australia

3Centre for Applied Statistics, University of Western Australia

4Department of Research, Sir Charles Gairdner Hospital, Perth, WA, Australia

Address for correspondence: Dr Colin Stewart, Department of Histopathology, King Edward Memorial Hospital, Perth, WA 6008, Australia. E-mail: colin.stewart@health.wa.gov.au

Received 13 August, 2014

Revised 19 September, 2014

Accepted 23 September, 2014

© 2015 Royal College of Pathologists of Australasia
You currently do not have access to this article

To access this article:

Note: If your society membership provides full-access, you may need to login on your society website